Results 11 to 20 of about 6,236 (164)
Therapeutic Advances in Infectious DiseaseIntroduction and objective: Pulmonary mucormycosis is a rare but rapidly progressive fatal disease. Limited data exist on the outcomes and factors associated with poor prognosis of pulmonary mucormycosis.
Rameesha Khalid +8 more
doaj +2 more sources
Prevalence, predictors and outcome of pulmonary mucormycosis in COVID-19 associated rhino orbital mucormycosis in a tertiary care centre in south India [PDF]
Current Medical Mycology, 2023 Background and Purpose: India witnessed an explosive rise in mucormycosis following COVID-19 infection. While rhino orbital mucormycosis was the most common presentation, pulmonary mucormycosis was closely followed.
Karthigeyan Thanjavur Sethuraman +3 more
doaj +1 more source
Clinical Features and Predictive Risk Factors for Prognosis in Invasive Pulmonary Aspergillosis and Pulmonary Mucormycosis. [PDF]
Clin Respir JPM patients exhibit distinctions from IPA in certain clinical characteristics, laboratory parameters, and chest radiology findings. Nevertheless, both PM and IPA patients experienced higher 30‐day mortality and ICU utilization. The combination of NLR and HbA1c with existing disease assessment tools proves effective in prognosticating the disease ...
Bai Y +5 more
europepmc +2 more sources
Pulmonary Mucormycosis: An Interesting Case of Rhizopus Mucormycosis [PDF]
Cureus, 2021 We report a case of a 57-year-old Vietnamese gentleman who presented with chest pain and shortness of breath for four weeks. The patient had a history of diabetes mellitus and kidney transplant in the past year and was currently on immunosuppressive agents.
Ukoha, Chijioke D, Nguyen, Nicholas
openaire +2 more sources
Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
European Journal of Medical Research, 2021 Background Mucormycosis is a rare fungal infection occurring chiefly in the lung or the rhino-orbital-cerebral compartment, particularly in patients with immunodeficiency or diabetes mellitus. Among Mucorales fungi, Rhizopus spp.
F. Yuan +5 more
doaj +1 more source
Three case reports of pulmonary mucormycosis with a review of the literature [PDF]
Frontiers in MedicineZhang Z, Wang M.
exaly +2 more sources
Isolated pulmonary mucormycosis [PDF]
BMJ Case Reports, 2017 An obese woman aged 70 years with a history of chronic persistent asthma and diabetes mellitus presented with acute exacerbation and respiratory failure. A chest X-ray and CT scan revealed patchy infiltrates on the right lung along with right hilar and upper lobe masses suggestive of malignancy (figure 1).
Raj Kumar, Mani +3 more
openaire +2 more sources
BMC Pulmonary Medicine, 2021 Background Pulmonary mucormycosis caused by Mucorales is a highly lethal invasive fungal infection usually found in immunocompromised patients. Isolated pulmonary mucormycosis in immunocompetent patients is very rare. Here, we present a case of a 32-year-
Jianhan He +4 more
doaj +1 more source
Archives of Internal Medicine, 1999 Pulmonary mucormycosis is relatively uncommon but an important opportunistic fungal infection in immunocompromised persons. The literature on the subject is sparse. We describe a recent case and review the literature to delineate the clinical characteristics of this infection.
F Y, Lee, S B, Mossad, K A, Adal
openaire +2 more sources
A Rare Case of Fatal Endobronchial Mucormycosis Masquerading as Endobronchial Tuberculosis
Medicina, 2020 Pulmonary mucormycosis is a relatively rare but often fatal opportunistic fungal infection that occurs mostly in immunocompromised patients. Endobronchial mucormycosis, a distinct clinical form of pulmonary mucormycosis, is very rare, and only a few ...
Minjeong Kim +5 more
doaj +1 more source